Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Ed A van de Graaf"'
Autor:
Onno M Mets, Suzan M Roothaan, Inez Bronsveld, Bart Luijk, Ed A van de Graaf, Aryan Vink, Pim A de Jong
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128062 (2015)
Lung disease in cystic fibrosis (CF) involves excessive inflammation, repetitive infections and development of bronchiectasis. Recently, literature on emphysema in CF has emerged, which might become an increasingly important disease component due to
Externí odkaz:
https://doaj.org/article/421df3eb8f5843aca6ee7bdf32c4bb9b
Autor:
Gerdien Belle-van Meerkerk, Pim A de Jong, Harold W de Valk, Tim Neefjes, Frank A Pameijer, Johanna M Kwakkel-van Erp, Ed A van de Graaf
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145597 (2015)
OBJECTIVES:Peri- and postoperative complications diminish the outcome of lung transplantation (LTx) in patients with cystic fibrosis (CF). We hypothesized that the degree of pathological findings on pre-LTx high resolution computed tomography (HRCT)
Externí odkaz:
https://doaj.org/article/ccbe340412c24accbbec1044b6c06326
Autor:
Maaike A. Sikma, Erik M. Van Maarseveen, Claudine C. Hunault, Javier M. Moreno, Ed A. Van de Graaf, Johannes H. Kirkels, Marianne C. Verhaar, Jan C. Grutters, Jozef Kesecioglu, Dylan W. De Lange, Alwin D. R. Huitema
Publikováno v:
Clinical Pharmacokinetics. 61:589-589
Autor:
Robin Vos, Dave Green, Rogier A.S. Hoek, Jacqueline M. Smits, Daniel Hoefer, Frank Langer, Erwin de Vries, Jens Gottlieb, Ed A. van de Graaf, Agita Strelniece, Geert Verleden, Christian Witt, Patrick Evrard, G.D. Nossent, Konrad Hoetzenecker, György Lang, Roland Buhl, Johanna M. Kwakkel-van Erp, Christiane Knoop, Undine Samuel, Guenther Laufer, René Schramm, Tobias Deuse, Benoît Rondelet
Publikováno v:
Transplant International, 31(8), 930-937. Wiley-Blackwell Publishing Ltd
Transplant International, 31(8), 930-937. Wiley
Transplant International, Vol. 31, no. 8, p. 930-937 (2018)
Transplant International, 31(8), 930-937. Wiley
Transplant International, Vol. 31, no. 8, p. 930-937 (2018)
Both Eurotransplant (ET) and the US use the lung allocation score (LAS) to allocate donor lungs. In 2015, the US implemented a new algorithm for calculating the score while ET has fine-tuned the original model using business rules. A comparison of bo
Autor:
Javier Moreno, Jan C. Grutters, Maaike A. Sikma, Marianne C. Verhaar, Alwin D. R. Huitema, Ed A. van de Graaf, J. H. Kirkels, Jozef Kesecioglu, Claudine C. Hunault, Dylan W. de Lange, Erik M. van Maarseveen
Publikováno v:
Clinical Pharmacokinetics
Background and Objective Abstract Therapeutic drug monitoring of tacrolimus whole-blood concentrations is standard care in thoracic organ transplantation. Nevertheless, toxicity may appear with alleged therapeutic concentrations possibly related to v
Autor:
Esther Pompe, Tim Besselink, Erik Jan D Oudijk, Ed A. van de Graaf, Pim A. de Jong, Bart Luijk, J.M. Kwakkel-van Erp, Firdaus A. A. Mohamed Hoesein
Publikováno v:
Lung
Lung, 194(5), 813. Springer New York
Lung, 194(5), 813. Springer New York
INTRODUCTION: Pulmonary hypertension (PH) in COPD is associated with a higher mortality and an increased risk on exacerbations compared to COPD patients without PH. The aim was to evaluate the diagnostic value of pulmonary artery (PA) measurements on
Autor:
Ed A. van de Graaf, Claudine C. Hunault, Marianne C. Verhaar, Dylan W. de Lange, Erik M. van Maarseveen, J. H. Kirkels, Jan C. Grutters, Maaike A. Sikma, Alwin D. R. Huitema, Jozef Kesecioglu
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics
European journal of drug metabolism and pharmacokinetics, 45(1), 123. Springer Paris
European journal of drug metabolism and pharmacokinetics, 45(1), 123. Springer Paris
Background and Objective Oral tacrolimus is initiated perioperatively in heart and lung transplantation patients. There have been few studies on oral tacrolimus pharmacokinetics early post-transplantation, even though tacrolimus-related toxicity may
Autor:
Diana A. van Kessel, Erik A M Verschuuren, Liesbeth ten Klooster, Bart Luijk, Wim van der Bij, Ed A. van de Graaf, Coline H.M. van Moorsel, Johanna M. Kwakkel-van Erp, Rogier A.S. Hoek, Bernt van den Blink, Peter Th. W. van Hal, Jan C. Grutters, G.D. Nossent, Erik Jan D Oudijk
Publikováno v:
Lung, 193(6), 919-926. Springer New York
Lung, 193(6), 919. Springer New York
Lung, 193(6), 919-926. SPRINGER
Lung, 193(6), 919. Springer New York
Lung, 193(6), 919-926. SPRINGER
Introduction Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal fibrosing lung disease with a median survival of approximately 3 years after diagnosis. The only medical option to improve survival in IPF is lung transplantation (LTX). The
Autor:
Arjan D. van Zuilen, Daniël Drop, Laura A. Michielsen, Kevin Budding, Henny G. Otten, Tineke Kardol-Hoefnagel, Marianne C. Verhaar, Ed A. van de Graaf
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 8 (2018)
Frontiers in Immunology, 8(JAN). Frontiers Media S. A.
Frontiers in Immunology, Vol 8 (2018)
Frontiers in Immunology, 8(JAN). Frontiers Media S. A.
Cellular protection against undesired effects of complement activation is provided by expression of membrane-bound complement regulatory proteins including CD59. This protein prevents membrane attack complex formation and is considered to be involved
Autor:
Hubertus D. Luijk, Erik-Jan Oudijk, Joost Jansen, Esther Pompe, Ed A. van de Graaf, Firdaus A. A. Mohamed Hoesein, Pim A. de Jong, Johanna M. Kwakkel-van Erp
Publikováno v:
Imaging.
Introduction: Measurement of blood eosinophil count in COPD is reported as a useful marker to identify patients with an increased risk for exacerbations. However, scarce information exists whether the degree of the blood eosinophil count has an impac